Drug Trial Radar · NCT06667999
The Intensive Care Platform Trial
Last checked: Nov 20, 2026Latest source record: Oct 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
10,000
Planned (sponsor's estimate)
Start
Jun 26, 2025
Primary completion
Dec 2035
Study completion Dec 2035
Sponsor
- Lead sponsor
- Anders PernerAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Copenhagen University Hospital, Rigshospitalet; Bispebjerg Hospital; Herlev Hospital; Hillerod Hospital, Denmark; Kolding Sygehus; Zealand University Hospital; Slagelse Hospital; Viborg Regional Hospital; Aalborg University Hospital; Aarhus University Hospital; Gødstrup Hospital; Copenhagen University Hospital, Hvidovre; Odense University Hospital; Randers Regional Hospital; University of Copenhagen; North Denmark Region; Region Capital Denmark; Region Zealand; University Medical Center Groningen; Steno Diabetes Center Copenhagen; Karolinska Institutet; Oslo University Hospital; University Hospital, Basel, Switzerland; Tampere University; Collaboration of Research in Intensive Care; Danish Intensive Care Database; The National University Hospital of Iceland
- First posted
- Oct 31, 2024
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Among critically ill patients, many die, and many of the survivors and their family members struggle for years with reduced quality of life. Critically ill patients are treated in intensive care units (ICUs). Here, they receive life support, e.g., mechanical ventilation and advanced support of the circulation (heart and blood vessels) and kidneys. In addition, ICU patients receive many other treatments. It is, however, uncertain if all the treatments provide value for the patients. The desirable effects of many treatments are uncertain, and some may be wasteful or even harmful. Clinical trials are necessary to validly assess the desirable and undesirable effects of different treatments. However, conventional clinical trials have limitations: * They typically only assess a single question related to a single comparison of treatments at a time. * They are often not very flexible, including with regards to the number of participants needed, and this increases the risk that a trial will end up as inconclusive. * There is no or limited re-use or sharing of infrastructure across trials, leading to duplicate work and resource use. * Trial participants do usually not benefit from the obtained knowledge before the trial concludes. * Involvement of patients, family members, and other stakeholders is typically limited, which may decrease the relevance of the questions addressed. With the Intensive Care Platform Trial (INCEPT), we aim to tackle these challenges by establishing a flexible platform trial that continuously learns from the obtained results. The platform trial may run forever with simultaneous and continuous assessment of many treatments. INCEPT will continuously learn from the accrued data and use these to improve the treatment of both participating and future patients. With INCEPT, we are also building a framework for thorough and extensive involvement of key stakeholders, including patients and family members. INCEPT will improve the way clinical trials are done and increase the probabilities that treatments are improved. This will: * Directly improve outcomes for ICU patients. * Relieve a strained healthcare system by discarding inefficient or harmful treatments. * Ensure that new treatments are beneficial or cost-effective before implementation. * Lower the costs and burdens of assessing more treatments in the critically ill.
Conditions
- Intensive Care Patients
- Intensive Care Unit Patients
- Critical Illness
Interventions
AlbuminDrug
Albumin should be used for the following indications: 1. During circulatory failure in addition to crystalloids (resuscitation). 2. For substitution in case of: suspected or overt albumin loss OR P-albumin levels below or equal to 25 g/L. Decisions around timing, volume, and concentration of albumin, and its use for other indications, are at the clinician's discretion. P-albumin should be measured according to local practice.
No albumin useOther
Albumin should not be used. In case of the following special circumstances, albumin may be considered: 1. Large ascites drainage (i.e., equal to or more than 1 L tapped) 2. Spontaneous bacterial peritonitis 3. Hepatorenal syndrome.
LMWH in weight-adjusted doseDrug
Patients with indication for thromboprophylaxis receive low-molecular-weight heparin (LMWH) in a weight-adjusted dose during their ICU stay. The treating clinician may decide to adjust or withhold one or more doses in case of acute and/or chronic kidney injury, renal replacement therapy, thrombocytopenia, invasive procedures, use of thrombolysis, and active (major) bleeding.
LMWH in fixed low doseDrug
Patients with indication for thromboprophylaxis receive low-molecular-weight heparin (LMWH) in a fixed low dose during their ICU stay. The treating clinician may decide to adjust or withhold one or more doses in case of acute and/or chronic kidney injury, renal replacement therapy, thrombocytopenia, invasive procedures, use of thrombolysis, and active (major) bleeding.
LMWH in fixed intermediate doseDrug
Patients with indication for thromboprophylaxis receive low-molecular-weight heparin (LMWH) in a fixed intermediate dose during their ICU stay. The treating clinician may decide to adjust or withhold one or more doses in case of acute and/or chronic kidney injury, renal replacement therapy, thrombocytopenia, invasive procedures, use of thrombolysis, and active (major) bleeding.
Primary outcomes
What the sponsor says the trial is designed to measure.
- One of the INCEPT core outcomes (varying between domains)Time frame: From randomisation to 30-180 days after randomisation.
- Days alive without life support at day 30 (Albumin domain)Time frame: From randomisation to 30 days after randomisation.
- Days alive and out of hospital at day 30 (Thromboprophylaxis domain)Time frame: From randomisation to 30 days after randomisation.
Locations
40 sites in 7 countries. Site status is shown where the registry gives one.
Medical University Of Vienna, Department of Anaesthesia, Intensive Care Medicine and Pain Medicine
Vienna, Austria · Not yet recruiting
Anaesthesia, Hospital Sønderjylland
Aabenraa, Denmark · Not yet recruiting
Department of Anaesthesia and Intensive Care, Aalborg University Hospital
Aalborg, Denmark · Recruiting
Department of Intensive Care Nord , Aarhus University Hospital
Aarhus, Denmark · Recruiting
Department of Intensive Care Øst, Aarhus University Hospital
Aarhus, Denmark · Recruiting
Department of Cardiothoracic Anaesthesia and Intensive care, Copenhagen Universisty Hospital - Rigshospitalet
Copenhagen, Denmark · Not yet recruiting
Department of Intensive Care, Copenhagen University Hospital - Rigshospitalet
Copenhagen, Denmark · Recruiting
Neuroanaesthesiology, Copenhagen University Hospital - Rigshospitalet
Copenhagen, Denmark · Not yet recruiting
Department of anesthesiology and intensive care, Bispebjerg-Frederiksberg Hospital
Copenhagen, Denmark · Recruiting
Esbjerg Hospital
Esbjerg, Denmark · Not yet recruiting
Department of Anesthesiology and Intensive Care, Copenhagen University Hospital Herlev
Herlev, Denmark · Not yet recruiting
Department of Anaesthesiology and Intensive Care, Gødstrup Hospital
Herning, Denmark · Recruiting
Department of Anaesthesia and Intensive Care Medicine, Copenhagen University Hospital - North Zealand
Hillerød, Denmark · Recruiting
Regional Hospital Horsens, Department of Anaesthesia, Surgery, and Intensive Care
Horsens, Denmark · Not yet recruiting
Anaesthesiology and Intensive Care, Amager and Hvidovre Hospital
Hvidovre, Denmark · Recruiting
Department of Anesthesia, Zealand University Hospital
Køge, Denmark · Recruiting
Department of Anesthesia and intensive care medicine, Kolding Hospital
Kolding, Denmark · Recruiting
Anesthesiology (ICU), Zealand University Hospital, Nykøbing Falster
Nykøbing Falster, Denmark · Not yet recruiting
Department of Anesthesiology and Intensive Care, Odense University Hospital
Odense, Denmark · Recruiting
Operation og Intensiv, Regional Hospital Randers
Randers, Denmark · Recruiting
Intensive care, Slagelse Hospital
Slagelse, Denmark · Recruiting
Department. of Anesthesiology and Intensive Care Medicine
Svendborg, Denmark · Recruiting
Department of Anaesthesiology and Intensive Care, Regional Hospital Viborg
Viborg, Denmark · Recruiting
East Tallinn Central Hospital, Centre of Anaesthesiology and Intensive Care
Tallinn, Estonia · Not yet recruiting
North Estonia Medical Centre Foundation, Intensive Care Centre
Tallinn, Estonia · Not yet recruiting
Tartu University Hospital, Anesthesiology and Intensive Care Clinic
Tartu, Estonia · Not yet recruiting
Perioperative and Intensive Care,, Helsinki University Hospital
Helsinki, Finland · Not yet recruiting
Department of Anesthesiology and Intensive Care, Hospital Nova of Central Finland
Jyväskylä, Finland · Not yet recruiting
Department of Anaesthesiology and Intensive Care, Kuopio University Hospital
Kuopio, Finland · Not yet recruiting
Anaesthesiology and Intensive Care Medicine, Tampere University Hospital
Tampere, Finland · Not yet recruiting
Department of Anaesthesiology and Critical Care Medicine, Landspitali - The National University Hospital of Iceland
Reykjavik, Iceland · Recruiting
Critical Care, University Medical Center Groningen
Groningen, Netherlands · Recruiting
Intensive Care, Martini Hospital Groningen
Groningen, Netherlands · Not yet recruiting
tensive Care Medicine, Maastricht UMC+
Maastricht, Netherlands · Not yet recruiting
Anesthesiology and Intensive Care, Antonius Ziekenhuis Sneek
Sneek, Netherlands · Not yet recruiting
Intensive and Perioperative Care, Skane University Hospital
Malmö, Sweden · Not yet recruiting
Södersjukhuset Sachsska Barnsjukhuset, Department of Anesthesia and Intensive care
Stockholm, Sweden · Not yet recruiting
Department of Anaesthesia and Intensive Care, Danderyd Hospital
Stockholm, Sweden · Not yet recruiting
Region Vaesternorrland, Department of Anesthesia and Intensive Care
Sundsvall, Sweden · Not yet recruiting
Perioperativ Medicin och Intensivvård, Karolinska Universitetssjukhuset
Stockholm, Solna, Sweden · Not yet recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.